Victoria A Brentville

5PUBLICATIONS
2CO-AUTHORS
Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 03, 2024
What do cancer-specific T cells 'see'?

Sabaria Shah, Abdullah Al-Omari, Katherine W Cook

|Oct 19, 2023
Vaccination with post-translational modified, homocitrullinated peptides induces CD8 T-cell responses that mediate antitumor immunity.

Sabaria Shah, Katherine W Cook, Peter Symonds

|Feb 10, 2022
PAD-2-mediated citrullination of nucleophosmin provides an effective target for tumor immunotherapy.

Ruhul H Choudhury, Peter Symonds, Samantha J Paston

|Jul 29, 2021
Homocitrullination of lysine residues mediated by myeloid-derived suppressor cells in the tumor environment is a target for cancer immunotherapy.

Katherine W Cook, Wei Xue, Peter Symonds

|Jun 21, 2020
Combination vaccine based on citrullinated vimentin and enolase peptides induces potent CD4-mediated anti-tumor responses.

Victoria A Brentville, Rachael L Metheringham, Ian Daniels

Pageof 1

Frequent Collaborators

3 joint publications

Katherine W Cook

2 joint publications

Ruhul H Choudhury